Oloniniyi Ibidunni Olapeju, Akinsulore Adesanmi, Aloba Olutayo Olubunmi, Mapayi Boladale Moyosore, Oginni Olakunle Ayokunmi, Makanjuola Roger
Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
J Neurosci Rural Pract. 2019 Jan-Mar;10(1):39-47. doi: 10.4103/jnrp.jnrp_210_18.
This study evaluated the economic cost of schizophrenia in Nigerian patients and identified factors that influence cost.
A total of 100 participants with schizophrenia were assessed using the modified economic cost questionnaire, the mini-international neuropsychiatric interview, the positive and negative syndrome scale, the Liverpool University Neuroleptic side-effect rating scale, and the global assessment of functioning scale. Associations between sociodemographic characteristics, illness-related variables and direct, indirect, and total costs of schizophrenia were assessed.
The average annual total, direct, and indirect costs of the treatment were $818.48, $349.59, and $468.89, respectively, per patient. The direct cost constituted 42.7%, while the indirect cost was 57.3% of the total costs of treatment. Hospitalization was the leading contributor to the direct cost, while productivity loss was a major component of the indirect cost.
Schizophrenia is an expensive disease in Nigeria, measures to reduce hospitalization could significantly reduce the cost of illness to the patient and their relatives.
本研究评估了尼日利亚精神分裂症患者的经济成本，并确定了影响成本的因素。
使用改良的经济成本问卷、迷你国际神经精神访谈、阳性和阴性症状量表、利物浦大学抗精神病药物副作用评定量表以及功能总体评定量表对总共100名精神分裂症患者进行评估。评估了社会人口学特征、疾病相关变量与精神分裂症的直接、间接和总成本之间的关联。
每位患者每年治疗的平均总成本、直接成本和间接成本分别为818.48美元、349.59美元和468.89美元。直接成本占42.7%，而间接成本占治疗总成本的57.3%。住院是直接成本的主要贡献因素，而生产力损失是间接成本的主要组成部分。
在尼日利亚，精神分裂症是一种昂贵的疾病，减少住院的措施可显著降低患者及其亲属的疾病成本。
